EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

CHAPTER-3 Phase 3 Trial Design: Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Extended-Release Tablet for Prophylaxis of Hereditary Angioedema Attacks

Sunday 15 Jun, 14:28 PM - 14:35 PM Glasgow, United Kingdom